Salesforce (CRM) Stock Forecast & Price Target

$332.01 +5.17 (+1.58%)

As of 03:01 PM Eastern

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 41 Analyst Ratings

Sell
1

Hold
6

Buy
34

Based on 41 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 41 analysts, 1 has given a sell rating, 6 have given a hold rating, 30 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$377.63
13.74% Upside

According to the 41 analysts' twelve-month price targets for Salesforce, the average price target is $377.63. The highest price target for CRM is $450.00, while the lowest price target for CRM is $236.00. The average price target represents a forecasted upside of 13.74% from the current price of $332.01.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

CRM Analyst Ratings Over Time

Type	Current Forecast 1/23/24 to 1/22/25	1 Month Ago 12/24/23 to 12/23/24	3 Months Ago 10/25/23 to 10/24/24	1 Year Ago 1/23/23 to 1/23/24
Strong Buy	4 Strong Buy rating(s)	4 Strong Buy rating(s)	4 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	30 Buy rating(s)	29 Buy rating(s)	25 Buy rating(s)	27 Buy rating(s)
Hold	6 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$377.63	$378.86	$312.51	$262.64
Forecasted Upside	13.74% Upside	10.49% Upside	8.99% Upside	-5.10% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.90	2.68	2.52
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	13.16% Upside	53.81% Upside	11.44% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/17/2025	TD Cowen 5 of 5 stars	J. Derrick Wood Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$380.00 ➝ $400.00	+24.62%
1/8/2025	Needham & Company LLC 2 of 5 stars		Boost Target	Buy ➝ Buy	$375.00 ➝ $400.00	+23.14%
1/6/2025	Guggenheim 2 of 5 stars	J. Difucci Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$247.00 ➝ $247.00	-25.80%
12/18/2024	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Beynon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$370.00 ➝ $370.00	+5.50%
12/18/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Outperform ➝ Market Outperform	$450.00 ➝ $450.00	+27.15%
12/18/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$425.00 ➝ $425.00	+21.08%
12/18/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$405.00 ➝ $405.00	+15.38%
12/13/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ader Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Weight ➝ Overweight	$440.00	+22.84%
12/4/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$340.00 ➝ $360.00	-2.16%
12/4/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$340.00 ➝ $380.00	+3.28%
Get the Latest News and Ratings for CRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salesforce and its competitors with MarketBeat's FREE daily newsletter.
12/4/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$400.00 ➝ $425.00	+15.51%
12/4/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$300.00 ➝ $420.00	+16.53%
12/4/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$368.00 ➝ $390.00	+7.93%
12/4/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Outperform ➝ Sector Outperform	$425.00 ➝ $440.00	+22.47%
12/4/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$315.00 ➝ $415.00	+14.17%
12/4/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$360.00 ➝ $400.00	+8.54%
12/4/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$385.00 ➝ $415.00	+25.09%
12/4/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$385.00 ➝ $425.00	+28.10%
12/4/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$380.00 ➝ $400.00	+20.57%
12/4/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$390.00 ➝ $425.00	+28.10%
12/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$415.00 ➝ $425.00	+28.10%
12/4/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$340.00 ➝ $430.00	+29.61%
12/4/2024	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$400.00 ➝ $440.00	+32.62%
12/4/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$390.00 ➝ $440.00	+32.62%
12/4/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$330.00 ➝ $405.00	+22.07%
12/3/2024	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$250.00 ➝ $300.00	-9.32%
11/22/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$275.00 ➝ $360.00	+5.26%
11/19/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
11/12/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$275.00 ➝ $330.00	-4.35%
10/17/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$343.00	+16.88%
10/2/2024	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Chokshi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/30/2024	Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Accumulate	$305.00	+20.72%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seyrafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Slowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$234.00 ➝ $236.00	-8.87%
8/29/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$335.00 ➝ $335.00	+28.58%
8/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Strong-Buy ➝ Strong-Buy	$325.00 ➝ $350.00	+35.19%
8/26/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$300.00 ➝ $300.00	+13.39%
5/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$350.00 ➝ $300.00	+39.82%
5/30/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$345.00 ➝ $300.00	+10.25%
Stunning Trump Manhattan Project Now Underway (Ad) Just as I predicted, President Trump announced his #1 move during his first 100 days... His allies are calling it Trump’s Manhattan Project. You simply have to see this..
4/16/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$365.00	+33.82%
3/6/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$290.00 ➝ $354.00	+16.46%
9/15/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$267.00	+22.04%
6/1/2023	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Baldry Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
6/1/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
3/2/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$140.00 ➝ $200.00	+19.51%
2/21/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$160.00 ➝ $170.00	+2.92%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:01 PM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, January 20, 2025. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

Salesforce, Inc. has recently reported a revenue of $9.44 billion for the quarter, exceeding analysts' expectations of $9.35 billion. This indicates strong demand for its Customer Relationship Management technology, which could lead to continued growth.
The stock has a current price of approximately $360.00, with a consensus rating of "Moderate Buy" from analysts. This suggests that many believe the stock has potential for appreciation.
Analysts have raised their price targets for Salesforce, with firms like Goldman Sachs and Scotiabank setting targets as high as $440.00. This reflects positive sentiment and confidence in the company's future performance.
Salesforce, Inc. has a solid market capitalization of $310.81 billion, indicating it is a well-established player in the market, which can provide stability for investors.
The company has a low debt-to-equity ratio of 0.14, suggesting it is not heavily reliant on debt for financing, which can be a sign of financial health and lower risk for investors.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

Despite strong revenue growth, Salesforce, Inc. reported an EPS of $2.41, which was below the consensus estimate of $2.44. This miss could raise concerns about the company's profitability and operational efficiency.
Insider selling has been significant, with a total of 1,183,838 shares sold valued at over $405 million in the last quarter. This could signal a lack of confidence from insiders regarding the company's future performance.
The stock has a high P/E ratio of 53.42, which may indicate that it is overvalued compared to its earnings. High valuations can lead to increased volatility and risk for investors.
Salesforce's quarterly dividend yield is relatively low at 0.49%, which may not be attractive for income-focused investors looking for higher returns from dividends.
The company has a beta of 1.30, suggesting that its stock price is more volatile than the market. This increased volatility can pose risks for investors, especially in uncertain market conditions.

CRM Forecast - Frequently Asked Questions

: According to the research reports of 41 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $377.63, with a high forecast of $450.00 and a low forecast of $236.00.
: 41 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last twelve months. There is currently 1 sell rating, 6 hold ratings, 30 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRM shares.
: According to analysts, Salesforce's stock has a predicted upside of 13.74% based on their 12-month stock forecasts.
: Over the previous 90 days, Salesforce's stock had 3 upgrades and 1 downgrade by analysts.
: Salesforce has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, Canaccord Genuity Group, Citigroup, DA Davidson, Erste Group Bank, Guggenheim, Jefferies Financial Group, JMP Securities, JPMorgan Chase & Co., KeyCorp, Loop Capital, Macquarie, Morgan Stanley, Needham & Company LLC, Northland Securities, Oppenheimer, Piper Sandler, Robert W. Baird, Royal Bank of Canada, Scotiabank, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, and Wells Fargo & Company in the past 90 days.
: Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.90 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:CRM) was last updated on 1/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target